Stories & Trends in Respiratory Nasal Sampling

When teams overlook the realities of real-world care in their medical device design process, inconsistency and risk follow. Explore how human factors engineering (HFE) and patient and clinician input help close these gaps early in development, translating clinical complexities into context-aware solutions equipped for stronger adoption.

In an article for Lab Manager, Dr. Nicholas Lorenzo shares how shelf-life constraints are shaping laboratory inventory planning and broader diagnostic readiness. He offers insight into how longer-lasting, higher-sensitivity collection methods like MicroWash can support more strategic preparedness as seasonal surge timelines shift.

Six years after the pandemic’s peak, healthcare leaders are still unpacking lessons learned from COVID. Explore the diagnostic challenges revealed — including inconsistent specimen collection, false negatives and testing avoidance — and how improved sampling methods can strengthen future outbreak response.

Early diagnostic clarity determines whether therapeutic intervention can begin in time to improve URI outcomes. Explores how infection progression impacts diagnoses, why nasal swabs fall short and how high-sensitivity nasal lavage paired with PCR supports stronger respiratory care decisions.

New antiviral evidence revealed baloxavir (Xofluza) as the superior flu treatment to oseltamivir (Tamiflu), and this emerging antiviral treatment strategy amplifies the consequences of delayed diagnoses. What does this mean for patients and healthcare systems, and how does smarter nasal sampling play a larger role than once thought?

In his latest article for MedCity News, Dr. Wadman explains why delivering a proper URI diagnosis within the first 96 hours after symptom onset is critical for stronger healthcare system operations and patient outcomes. That pivotal window guides everything that follows, from individual treatment decisions to large-scale outbreak control.

Patient experience is one of the most powerful drivers of a healthcare system’s financial, reputational and operational resilience. Discover the often-overlooked downstream impact of intrusive nasal swabs, and why evolved nasal lavage is the more comfortable, sensitive and ultimately cost-effective solution for modern healthcare systems.

Dr. Lorenzo was recently featured in an in-depth Q&A with Authority Magazine to give an inside look into his upbringing, education, mentorship and leadership path. Discover the origins that shaped his mission to strengthen diagnostic preparedness and public health through better sampling methods like MicroWash.

The MicroWash nasal lavage device gives laboratories a more efficient collection method that supports high-sensitivity results and smooth integration into existing PCR processes. Here are the top five questions we receive from lab professionals, answered.

With 90 inventions to his credit, two successful startups, two U.S. patents secured and another five pending, Dr. Nguyen claimed the Faculty Entrepreneur distinction at UNeMed’s Research Innovation Awards and was welcomed to its Innovation Ambassadors cohort.